Table 1 Characteristics of the population and differences among controls (M0) and women affected by peritoneal carcinomatosis (M1: peritoneum) or other site of metastases (M1: other than peritoneum)
From: Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer
M0 | M1 | M1 | p | |
|---|---|---|---|---|
Other than peritoneum | Peritoneum | |||
Age at diagnosis (years) | 60.19 (± 12.92) | 60.07 (± 14.2) | 56.59 (± 12.52) | NS |
BMI (kg/m2) | 25.89 (± 4.9) | 25.86 (± 5.11) | 22.42 (± 4.97) | (2, 3) |
Tobacco smoke | 7.5 % (168/2230) | 4.3 % (9/208) | 0 % (0/19) | NS |
Familial history of breast cancer | 36 % (283/787) | 33.9 % (21/62) | 50 % (1/2) | NS |
Use of OC | 29.7 % (156/525) | 24.5 % (12/49) | 0 % (0/2) | NS |
Post-menopausal status | 79.6 % (2110/2652) | 78.1 % (196/251) | 70 % (14/20) | NS |
First breast surgical treatment | ||||
Breast conserving surgery | 62.9 % (1767/2807) | 33.7 % (90/267) | 54.5 % (12/22) | (1, 3) |
Mastectomy | 37.1 % (1040/2807) | 66.3 % (177/267) | 45.5 % (10/22) | (1, 3) |
Axilla surgical treatment | ||||
CALND | 53.8 % (1511/2807) | 90.3 % (241/267) | 86.4 % (19/22) | (1,2) |
SLNB | 42.5 % (1194/2807) | 5.6 % (15/267) | 9.1 % (2/22) | (1, 2) |
None | 3.6 % (102/2807) | 4.1 % (11/267) | 4.5 % (1/22) | NS |
Second breast surgical treatment | ||||
None | 77 % (1285/1669) | 65.9 % (54/82) | 81.8 % (9/11) | (1) |
Breast conservative surgery | 10.7 % (178/1669) | 14.6 % (12/82) | 0 % (0/11) | NS |
Mastectomy | 12.3 % (206/1669) | 19.5 % (16/82) | 18.2 % (2/11) | NS |
Other treatments | ||||
Neoadjuvant | 5.6 % (158/2807) | 15.7 % (42/267) | 9.1 % (2/22) | (1) |
Adjuvant radiotherapy | 58 % (1561/2690) | 47.8 % (121/253) | 50 % (11/22) | (1) |
Adjuvant chemotherapy | 39.1 % (1051/2687) | 82.9 % (208/251) | 86.4 % (19/22) | (1, 2) |
Adjuvant hormonal therapy | 79.7 % (2140/2684) | 64.5 % (162/251) | 72.7 % (16/22) | (1) |